The Global Liquid Biopsy Market Research Report published by Emergen Research is furnished with the latest information about product specifications and portfolio, technological advancement, product type, and manufacturing. Major factors such as revenue, costs, and gross margin are taken into consideration while formulating this report. The report provides extensive data concerning the key market players along with their SWOT analysis, financial standing, technological and product development, and recent strategic business expansion plans.
The global liquid biopsy market size is expected to reach USD 7,645.0 Million in 2030 and register a revenue CAGR of 20.3% over the forecast period, according to the latest analysis by Emergen Research. Rise in demand for early cancer detection is a key factor driving global liquid biopsy market revenue growth.
Liquid biopsy is a safe and popular procedure carried out during examination of cancer. The procedure is easy and minimally invasive, allows early detection and diagnosis of cancer, and helps in identification of cancer treatment. In addition, growing popularity of non-invasive techniques is driving private and public financing for research in the field of liquid biopsy, which allow medical professionals to discover various aspects of a tumor through a patient’s blood sample. It facilitates medical professionals to understand, which treatments are suitable for patients.
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/liquid-biopsy-market
Key insights presented in the report:
- Market revenue shares by major business players, by type, by application, and market scope of global Liquid Biopsy market
- Sales revenue by key players and new entrants
- Competitive analysis of key players, including aspects such as company overview, product or services specification, vendors, and buyers
- Recent mergers, acquisitions, product launches, recent investments, and joint ventures
- Regional analysis to provide insight into recent trends and opportunities
The report provides comprehensive details about the market with respect to overall revenue, sales and consumption, pricing trends, gross margins, growth rate, and market size. Additionally, the report also covers details of the company, such as sales and distribution area, product portfolios, specifications, and others.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/34
The report also discusses key players involved in the market, such as Bio-Rad Laboratories, Inc., Adaptive Biotechnologies, NeoGenomics Laboratories, Guardant Health, Biocept, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., MDxHealth, Menarini Silicon Biosystems, and Agena Bioscience, Inc. as well as new entrants in the market. The competitive analysis also includes regional analysis of major geographical regions. The report covers regions such as North America, Europe, Asia Pacific, Latin America, and Middle East Africa.
Key Questions Answered in the Report:
- What will be the estimated growth rate of the Liquid Biopsy market by 2027?
- Who are the prominent distributors, vendors, and manufacturers of the market?
- What are the driving and restraining factors of the growth of the Liquid Biopsy market throughout the forecast period?
- What are the current and future market trends of the Liquid Biopsy market?
- What are the sales and price analysis of the product by types, applications, and regions?
- What are the expected opportunities for the companies and new entrants in the coming years?
Emergen Research has segmented the global liquid biopsy market based on product type, circulating biomarkers, sample type, technology, disease, application, end-use, and region:
Product Type Outlook (Revenue, USD Million; 2019–2030)
- Assays Kits
- Instruments
- Services
Circulating Biomarkers Outlook (Revenue, USD Million; 2019–2030)
- Circulating Tumor DNA (ctDNA)
- Circulating Tumor Cells (CTCs)
- Extracellular Vesicles (EVs)
- Cell-Free DNA (cfDNA)
- Others
Sample Type Outlook (Revenue, USD Million; 2019–2030)
- Blood Sample
- Urine Sample
- Others
Technology Outlook (Revenue, USD Million; 2019–2030)
- Multi-gene-parallel Analysis (NGS)
- Single Gene Analysis (PCR Microarrays)
Disease Outlook (Revenue, USD Million; 2019–2030)
- Oncology
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Melanoma Cancer
- Others
- Non-cancer
- Oncology
Application Outlook (Revenue, USD Million; 2019–2030)
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring Orthopedics
End-Use Outlook (Revenue, USD Million; 2019–2030)
- Hospitals Physician Laboratories
- Reference Laboratories
- Academic Research Centers
- Others
The report demonstrates the progress and advancement achieved by the global Liquid Biopsy market, including the historical analysis and progress through forecast years. The report provides valuable insights to the stakeholders, investors, product managers, marketing executives, and other industry professionals. The report provides an accurate estimation by applying SWOT analysis and Porter’s Five Forces analysis. The report focuses on current and future market growth, technological advancements, volume, raw materials, and profiles of the key companies involved in the market.
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/34
Thank you for reading our report. Please get in touch with us if you have any queries regarding the report or its customization. Our team will ensure the report is best suited to your needs.
